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Abstract 34 
Background: E-cigarettes are the most popular aid to smoking cessation attempts in England and 35 
the United States of America. This research examined associations between e-cigarette device 36 
characteristics and patterns of use, tobacco smoking relapse and smoking abstinence.  37 
Methods: A convenience sample of 371 participants with experience of vaping, and tobacco smoking 38 
abstinence and/or relapse completed an online cross-sectional survey about e-cigarettes. Factors 39 
associated with smoking relapse were examined using multiple linear and logistic regression models.  40 
Results: Most participants were self-reported long-term abstinent smokers (86.3%) intending to 41 
continue vaping. Most initiated e-cigarette use with a vape pen (45.8%) or cig-a-like (38.7%) before 42 
moving onto a tank device (89%). Due to missing data, managed through pairwise deletion, only 43 
around 70 participants were included in some of the main analyses. Those using a tank or vape pen 44 
appeared less likely to relapse than those using a cig-a-like (tank vs. cig-a-like OR=0.06, 95% CI 0.01 45 
to 0.64, p=0.019). There was an inverse association between starting self-reported e-cigarette liquid 46 
nicotine concentration and relapse, interacting with device type (OR=0.79, 95% CI 0.63 to 0.99, 47 
p=0.047), suggesting risk of relapse may have been greater if starting with a low e-cigarette liquid 48 
nicotine concentration and/or cig-a-like device. Participants reported moving from tobacco flavoured 49 
cig-a-likes to fruit/sweet/food flavours with tank devices.  50 
Conclusions: Knowledge of how people have successfully maintained tobacco smoking abstinence 51 
using vaping could help other tobacco smokers wishing to quit tobacco smoking through vaping. 52 
 53 
Keywords: e-cigarettes; smoking relapse; cross-sectional survey 54 
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1. Background 59 
E-cigarette use, known as “vaping”, is thought to be less harmful than tobacco smoking(1) and e-60 
cigarettes are the most popular aid to smoking cessation attempts in England(2) and the United States 61 
of America (USA)(3). Estimated current e-cigarette use prevalence among tobacco smokers in the 62 
United Kingdom (UK) is 21.9%, and 36.5% report ‘ever use’(4). In the USA 15.9% report current use 63 
and 47.6% ever use(5). Regular (at least weekly) e-cigarette use among never smokers in Great Britain 64 
has been very rare (<1%)(4) and past week vaping by never-smoking adolescents in the USA was 3% 65 
in a 2018 survey(6).  66 
E-cigarettes are electronic devices that heat ‘e-liquid’ (usually comprised of propylene glycol and 67 
glycerol, with or without nicotine and flavours) stored in a disposable/refillable cartridge/reservoir to form 68 
an aerosol for inhalation(7). E-cigarettes are commonly referred to as being first-, second- or third- 69 
generation(Figure 1). First-generation devices are typically ‘cig-a-likes’ designed to look and feel like 70 
tobacco cigarettes and use prefilled cartridges(8). Second-generation devices generally appear like 71 
pens, use tanks that can be re-filled and have larger battery capacity. Third-generation devices use re-72 
fillable tanks and allow modifications to the voltage and/or wattage output, improving performance and 73 
allowing a tailored user experience. Pod devices, designed to combine the simplicity of cig-a-likes with 74 
the user experience of third-generation devices, were released onto the market in the USA in 2015 and 75 
subsequently became available in the UK(4).  76 
Use of e-cigarettes has grown rapidly and may support smoking cessation, but there is little 77 
evidence on long term health effects or sustained smoking cessation. A Cochrane review(7) identified 78 
two randomised controlled trials (RCTs)(9,10) suggesting e-cigarettes are more effective for smoking 79 
cessation compared with placebo e-cigarettes and one RCT found no significant differences between 80 
e-cigarettes and nicotine patch. However, overall evidence was low quality. Two large RCTs have been 81 
published since completion of this Cochrane review. An RCT comparing provision of free cartridge e-82 
cigarettes with low nicotine delivery, compared with nicotine patches, suggested a similar low efficacy 83 
for both treatments (1% and 0.5% sustained abstinence at 6 months respectively)(11). An RCT 84 
comparing a group assigned to an e-cigarette starter pack (second-generation refillable e-cigarette, one 85 
bottle of 18mg e-liquid and recommendations to purchase further liquid of their choice) and a group 86 
assigned to nicotine replacement therapy (NRT) of their choice, both with associated behavioural 87 
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support, found 18.8% one year biochemically verified smoking abstinence in the e-cigarette group 88 
compared with 9.9% in the NRT group (RR 1.83; 95% CI 1.30 to 2.58, p<0.001)(12). 89 
 90 
 91 
Figure 1- Examples of first, second and third generation e-cigarettes 92 
Most attempts at smoking cessation result in relapse, and smokers generally make multiple quit 93 
attempts before succeeding(13). Qualitative research suggests e-cigarettes can meet many of the 94 
needs of ex-smokers by substituting physical, psychological, social, cultural and identity related aspects 95 
of tobacco addiction(14,15).  According to a time-series analysis of data from the Smoking Toolkit study, 96 
in which repeated cross-sectional surveys are conducted with a representative sample of households 97 
in England, increasing prevalence of e-cigarette use in current smokers was predictive of higher 98 
success rates of quit attempts(16).  99 
There is evidence that how people use e-cigarettes, in terms of device type and patterns of use, 100 
can affect number and success rate of quit attempts. Brose et al. found that daily, but not non-daily, e-101 
cigarette use is predictive of greater cigarette cessation attempts and reduced smoking among UK 102 
adults(17). Evidence suggests abstinence from smoking may be significantly higher among tank 103 
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users(18). Another determining factor in e-cigarette effectiveness is the nicotine concentration used. 104 
The amount of nicotine delivered varies depending on a range of characteristics, including the device 105 
(e.g. model, wattage), e-liquid (e.g. flavour, ingredients, pH) and user behaviour (e.g. puffing 106 
topography)(19,20). A Cochrane review of NRT for smoking cessation suggested heavier smokers 107 
required higher nicotine doses(21). According to an ethnographic study, vape shops recommend higher 108 
e-liquid nicotine concentrations for heavier smokers(22), but this is not yet backed up by robust 109 
evidence. 110 
Current understanding of how e-cigarette users, known as ‘vapers’, use e-cigarettes to avoid 111 
smoking relapse, is limited. This study reports results of an online survey from a convenience sample 112 
of vapers to elucidate patterns of use and types of devices that might best support ongoing tobacco 113 
smoking abstinence. Hypotheses were generated based on the associated qualitative study(15). We 114 
hypothesised: 115 
1. Those who initiate vaping using a first-generation device are more likely to relapse to tobacco 116 
smoking than those initiating using a later generation device;  117 
2. Those who start on a low self-reported nicotine e-liquid concentration (strength) will be more likely 118 
to relapse to tobacco smoking than those starting on a higher nicotine e-liquid, after controlling for 119 
cigarettes per day (CPD) before cessation;  120 
3. There will be a relationship between lower nicotine strength, interacting with device type, and 121 
relapse, as newer generation devices provide nicotine more efficiently(23). 122 
2. Methods  123 
2.1. Participants 124 
A convenience sample of UK vapers were invited to participate in an online survey, combining 125 
fixed choice and open-ended responses, collecting quantitative and qualitative data. This paper reports 126 
analyses of the quantitative data collected.  127 
Participants who self-reported a history of tobacco smoking, experience of using an e-cigarette 128 
and tobacco smoking abstinence or relapse following e-cigarette use, were initially recruited to 129 
participate in a qualitative study(15,24). When the qualitative study reached ‘saturation’, further 130 
volunteers were diverted to the survey. Recruitment was through word of mouth, press articles, 131 
university bulletins, and social media. 132 
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2.2. Procedure 133 
Informed consent was obtained. Question items were designed based on topics from the 134 
accompanying qualitative study. Questions were asked on socio-demographic characteristics, tobacco 135 
variables, e-cigarettes and previous quit attempts. Data on relapse were obtained by asking participants 136 
whether they were abstinent from smoking after using their first device (“yes” or “no, I relapsed“). For 137 
data on e-cigarette device use, we asked “What type of e-cigarette device did you try first? Please 138 
select the picture that looks most like the device you started with”, “Did your first device help you stay 139 
stopped from smoking tobacco?” and “What type of e-cigarette device do you currently use the most?” 140 
There were two versions of the survey which were combined for analysis. One of the questions 141 
from Version 1 (V1 n=183) on devices used was poorly completed and complex and was re-designed 142 
for Version 2 (V2 n=188). V1 asked participants to list devices they have used in the order they used 143 
them, starting with the first one tried to the one currently used. Free-text boxes were provided for the 144 
device name, wattage, nicotine strength (e.g. 12mg, 6mg) and flavourings (e.g. tobacco, fruit). V2 asked 145 
participants to select the type of device they tried first and the device used currently in a multiple-choice 146 
question including cig-a-like, vape pen, mod and tank, and other. Options were accompanied by an 147 
example photo. They were then asked to detail in free text boxes their current and starting flavour (e.g. 148 
tobacco, fruit) and nicotine strength. Free text responses on device type from V1 were coded as per the 149 
categories for V2 and included in this analysis. Data described below includes participants from both 150 
versions.  151 
The study received ethical approval from the University of East Anglia Faculty of Medicine and 152 
Health Sciences Research Ethics Committee. 153 
2.3. Analysis 154 
Participant characteristics, tobacco and e-cigarette variables were examined with descriptive 155 
statistics. Binary logistic regression was used to examine associations between device type or nicotine 156 
strength and current/previous self-reported relapse. Relapse was defined as ‘a successful smoking quit 157 
attempt of at least 48 hours, followed by a relapse (more than five instances of smoking) to tobacco 158 
smoking’. This was chosen  in order to capture both early and late relapsers, whilst excluding dual users 159 
and triallers (those who use e-cigarettes alongside tobacco smoking without making a serious quit 160 
attempt). Five episodes were required for relapse as per the Russell Standards which allow up to five 161 
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cigarettes to be smoked for an individual still to be considered smoking abstinent(25). After examining 162 
these associations, the interaction between device type and strength and its possible association with 163 
relapse was investigated by adding an interaction term for strength and device to the model. 164 
Multiple linear regression was used to examine associations between CPD and e-liquid nicotine 165 
starting strength.  166 
Missing data were dealt with through pairwise deletion in order to increase power. Where 167 
percentages are reported in the results section, this is the percentage of those for whom there were 168 
data available for that variable. Where “n” is used in the results section this is the absolute number of 169 
participants who gave that response, so where there is missing data this will not total 371.  170 
All models were built up step wise, controlling for age and sex, followed by CPD.   171 
In the results section descriptive statistics are presented, followed by the results for each of the three 172 
hypotheses tested.  173 
3. Results 174 
3.1 Descriptive statistics 175 
509 participants entered the online survey (V1 n=249, V2 n=260). Of these, 27.1% did not give 176 
consent to participate and were discarded (V1 n=66, V2 n=72), leaving 371 participants (V1 n=183; V2 177 
n=188). Of these 371 participants’ the number of responses to individual questions varied. Questions 178 
on flavours, device types, e-liquid nicotine strengths and vaping status were answered by more than 179 
60% of the 371 participants. Questions on smoking status were answered by 56.9% of participants. 180 
Questions on relapse, the main outcome variable, were only answered by 42% of participants. Sample 181 
sizes for key outcomes are presented in Figure 2. 182 
 183 
 184 
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Figure 2. Survey participant flow diagram. 202 
3.1.1 Demographic characteristics 203 
23.6% of participants were female and mean age was 49 (SD 11.61, range 22-78). Participants 204 
came from across the UK. Eight participants (<1%) reported living outside of the UK.  205 
Half of participants (50.0%) were married (n=108/216), 26.4% were single (n=57/216), 14.8% were 206 
cohabiting (n=32/216), 6.0% were divorced (n=13/216) and 2.7% were widowed (n=6/216).  207 
92.3% (n=84/91) described themselves as “White”, 10.7% (n=9/91) of whom specified “White 208 
European”. The remainder were “Mixed” (n=6/91) or “Asian” (n=1/91).   209 
Regarding occupation, 24.1% (n=39/162) described themselves as “retired” and 6.2% 210 
(n=10/162) “self-employed”. The remaining 69.7% of participants were in work (n=113/162) and were 211 
classified according to the NRS Social Grade classification. Of those in work, 19.1% (n=22/113) were 212 
social grades A and B, 47.6% (n=53/113) social grades C1 and C2 and 33.3% (n=38/113) grades D 213 
and E.  214 
 215 
 216 
Participants entered 
online questionnaire 
Version 1 (n=249) 
Participants entered 
online questionnaire 
Version 2 (n=260) 
Participants consented 
to participate (n=183) 
Participants consented 
to participate (n=188) 
Did not 
consent V1 
(n=66) 
Did not 
consent V2 
(n=249) 
Total participants in online questionnaire (n=371) 
 
Included participants for main analyses (reduced due to missing data):  
Device type and relapse n=79 
Starting strength and CPD n=192 
Starting strength, interacting with device type, and relapse n=72 
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3.1.2 Smoking and vaping status 217 
Most participants were long-term abstinent from tobacco smoking (defined as ≤5 instances of one-218 
off tobacco smoking relapse in the last 12 months)(86.3%, n=182/211), >99% of whom continued to 219 
vape. A further 10.4% had recently quit smoking and were vaping (n=22/211) and 3.1% (n=7/211) were 220 
vaping and occasionally smoking. Most intended to continue vaping (85.4%, n=194/227). <1% had 221 
already stopped using e-cigarettes.   222 
Of those still using e-cigarettes (n=256), the average reported duration of use was 3.9 years (SD 223 
2.3, range 1 month to 9.8 years). 224 
3.1.3 Self-reported e-liquid nicotine concentration (strength) used 225 
Mean initial nicotine strength was 19.84 mg (SD 8.97, range 0-48 mg), reducing to an average 226 
7.96 mg with their current device (SD 7.06, range 0-36 mg). Higher mean CPD generally appeared to 227 
coincide with higher starting strength, except in the group starting with 0-6mg nicotine e-liquid(Table 1).    228 
Table 1. Starting e-liquid nicotine strengths and cigarettes per day.  229 
Starting 
strength (mg) 
Participants 
(n=200) 
Mean CPD 
0-6* 21 28.3 
7-12 25 23.8 
13-18 67 28.2 
19-24 57 30.5 
25+ 30 36.8 
*Note only a single participant reported using 0mg/ml as a starting e-liquid nicotine concentration. 230 
3.1.4 Self-reported e-liquid flavours used 231 
Results suggest a change in flavour choices over the course of vaping initiation and uptake. There 232 
was a reduction in the proportion of people using a tobacco flavour (-36.5%, 95% CI -43.5 to -29.6), 233 
and increase in the proportion using a fruit/sweet/food flavour (+31.7%, 95% CI 23.3% to 40.0%), from 234 
initial to current flavour choice(Table A1). 235 
 236 
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3.1.5 Self-reported devices used 237 
Most participants reported their initial device was either a vape pen (second generation)(45.8%) or 238 
cig-a-like (first generation)(38.7%). Most reported their current device to be a mod and tank (third 239 
generation)(89.4%).  240 
No differences in demographic characteristics of those who chose different initial devices were 241 
identified (Table A2).  242 
Among those who became successfully abstinent from smoking using their first device (44.9%, 243 
n=71), 71.8% (n=51) switched to another device, all of whom moved from an earlier to later generation 244 
device. Of those who became successfully abstinent from smoking using their first e-cigarette device 245 
and continued to use the same or a similar type of device (n=20), 65.0% (n=13) had started with a mod 246 
and tank device, 24.0% (n=5) a vape pen and only two successfully stopped smoking with, and 247 
continued to use, a cig-a-like.     248 
Coded self-reported reasons as to why participants moved on from their first device indicate that 249 
most wished to upgrade to a device they perceived as better (n=57) or to move on from a device they 250 
considered inadequate for their needs (n=21) due to battery life/power, flavour and improved 251 
technology. Some wished to upgrade to enjoy opportunities to personalise their device or as a hobby 252 
(Table A3). Mean number of devices tried was 5.4 (SD 2.96, range 1-15, n=98).  253 
 254 
3.2 Hypothesis 1: Those who initiate vaping using a first-generation device are more likely to relapse to 255 
tobacco smoking than those initiating using a later generation device 256 
Only 44.9% (n=71/158) reported successful tobacco abstinence after using their first device. 24.7% 257 
(n=39/158) reported dual use, 18.4% (n=29/158) full relapse and 12.0% (n=19/158) occasional lapses. 258 
Relapse appeared more common among those using a cig-a-like, compared with a vape pen or a mod 259 
and tank(Table 2). 260 
 261 
 262 
 263 
 264 
 265 
 266 
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Table 2. Device types and relapse.  267 
Device type 
Initial device 
type (n=238) 
Relapse with initial device 
(n=98 asked and responded 
to this question) 
Final device type 
(n=235) 
Cig-a-like 92 (38.66%)1 22/42 (52.38%) 3 (1.28%) 
Vape pen 109 (45.80%) 6/40 (15%) 22 (9.36%) 
Mod and tank 38 (16.00%) 1/16 (6.25%) 210 (89.36%) 
All 238 29/98 (29%) 235 
1 Note percentages do not total exactly 100 due to rounding. 268 
Those using a mod and tank device (n=16/98), or a vape pen (n=40/98), on initiation were 269 
significantly less likely to relapse than those using a cig-a-like (n=42/98) (mod and tank vs. cig-a-like 270 
OR=0.06, 95% CI 0.01 to 0.50, p=0.009; vape pen vs. cig-a-like OR=0.16, 95% CI 0.06 to 0.46, p=0.001, 271 
n=98). This difference remained after controlling for age and sex (mod and tank vs. cig-a-like OR=0.06, 272 
95% CI 0.01 to 0.64, p=0.019; vape pen vs. cig-a-like OR=0.14, 95% CI 0.04 to 0.51, p=0.003, n=79).  273 
 274 
3.3 Hypothesis 2: Those who start on a low self-reported nicotine e-liquid concentration (strength) will 275 
be more likely to relapse to tobacco smoking than those starting on a higher nicotine e-liquid, after 276 
controlling for cigarettes per day (CPD) before cessation 277 
Mean initial nicotine strength was 19.84 mg (SD 8.97, range 0-48 mg) and mean current nicotine 278 
strength was 7.96 mg (SD 7.06, range 0-36 mg), suggesting most participants reduced nicotine strength 279 
over time.  280 
Splitting data on initial e-liquid nicotine strengths into quartiles suggested those with higher 281 
reported CPD may use higher starting strengths. A simple linear regression was calculated to predict 282 
starting nicotine strength based on CPD. A significant association was found, with nicotine strength 283 
increasing by 0.1mg for every extra cigarette smoked per day (95% CI 0.025 to 0.187, p=0.01, n=200). 284 
The strength of the association reduced slightly but remained statistically significant after controlling for 285 
age and sex (0.08mg increase, 95% CI 0.003 to 0.164, p=0.041, n=192).  286 
There was no association between initial self-reported e-liquid nicotine content and relapse 287 
(OR=1.00, 95% CI 0.95 to 1.05, p=0.895, n=100) and there continued to be no association after 288 
controlling for age, sex, device type and CPD (OR=1.01, 95% CI 0.95 to 1.09, p=0.677, n=72). 289 
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3.4 Hypothesis 3: There will be a relationship between lower nicotine strength, interacting with device 290 
type, and relapse, as newer generation devices provide nicotine more efficiently[20] 291 
After adding an interaction term for initial strength and device type, there was a small but 292 
statistically significant inverse association between starting strength and relapse (OR=0.79, 95% CI 293 
0.63 to 0.99, p=0.047, n=72). There was a significant interaction term for the device type and nicotine 294 
strength interaction (OR=1.18, 95% CI 1.02 to 1.37, p=0.026, n=72). 295 
4. Discussion 296 
This study of real-world patterns of e-cigarette use suggests choice of products and liquids may 297 
impact tobacco smoking relapse.  298 
Relapse was much more likely among people initiating e-cigarette use with a cig-a-like, compared 299 
with other types of device. According to an ethnographic study, vape shops sometimes separate 300 
devices into ‘beginner’, ‘intermediate’ and ‘advanced’ in displays(22). Cross-sectional surveys by 301 
McNeill et al. suggested newer e-cigarette designs were more effective for smoking cessation (38.0%) 302 
than older ones(19.9%)(18,26). A study of 50 smokers unwilling to quit who were provided with second 303 
generation e-cigarettes found 36% CO verified smoking abstinence after 24 weeks(27). An online 304 
survey by Etter suggested that users perceived tank devices as more effective than pre-filled models 305 
for smoking cessation(28). Our study supports these findings but classified devices into three categories 306 
(cig-a-like, vape pen and tank), providing additional granularity. As our data is cross-sectional, it is 307 
unclear whether progressing from a simpler device to a more complex one is beneficial, such as 308 
allowing the user to develop skills in adapting their device to suit their needs, or if new users should be 309 
recommended to start with a newer device.      310 
Most shops in an ethnographic study of vape shops used ‘rules of thumb’ when recommending 311 
nicotine strengths to customers(22). Smokers of ≤10 CPD are recommended 3-6mg nicotine, 10-20 312 
CPD 6-12 mg and 20+ CPD 18 mg. Our results suggest that in practice vapers who reported higher 313 
CPD generally start with higher nicotine strength e-liquids, but that perhaps some smokers are starting 314 
on strengths insufficient for their needs. Mean CPD for those starting on 0-6mg nicotine was 28.3, much 315 
higher than the 10 CPD advised by vape shops(Table 2). Mean initial nicotine strength was 19.84 mg 316 
(SD 8.97, range 0-48 mg), reducing to an average 7.96 mg with their current device (SD 7.06, range 0-317 
36 mg). The upper limit of nicotine in e-liquid in England is 20 mg/mL, and the maximum tank capacity 318 
2 mL, as of May 2016, with a transition period until May 2017. The upper reported strength of 48 mg is 319 
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beyond this limit, perhaps as they initiated vaping prior to transition or outside England, or due to errors 320 
in recall. 321 
This study supports others suggesting vapers decrease their e-liquid nicotine strength over 322 
time(29–31), although those studies suggest users compensate for this by changing puffing patterns 323 
and using more e-liquid, maintaining cotinine levels. Research has shown that nicotine delivery is a 324 
function of device power, e-liquid nicotine concentration, and topography. Our study suggests 325 
participants may be transitioning from cig-a-likes with lower power and higher nicotine e-liquid 326 
concentrations to mod and tank devices with greater power and lower e-liquid nicotine concentrations. 327 
Whilst self-reported e-liquid nicotine concentration decreased, users may be taking in similar/more 328 
nicotine from these later generation devices than the low power/high nicotine devices that have been 329 
shown to deliver nicotine poorly. We cannot tell from this study how nicotine intake changes over time. 330 
This study reports novel findings suggesting starting on insufficient levels of nicotine based on 331 
previous CPD, combined with a less powerful device, may lead to greater risk of relapse. Sample size 332 
for that analysis was only 72, so further exploration of this hypothesis with a larger sample size, allowing 333 
for the inclusion of more confounders within the model, is warranted.  334 
According to the 2017 ASH-A survey, among current users, fruit flavours were the most popular 335 
(28.5%), followed by tobacco (26.9%) and menthol/mint flavours (25.3%)(1). Previous studies 336 
suggested fruit flavoured e-liquids are more popular among young people(31). Our results suggest a 337 
change in flavour choices over time. We saw a significant reduction in use of tobacco flavour and 338 
increases in use of fruit/sweet/food flavours from initial to current flavour choice. An online survey by 339 
Russell et al. in the USA reported that initiating e-cigarette use with a tobacco flavoured e-liquid became 340 
less common between pre-2011 and 2015/16, and sweet flavours became more common(32). Litt et al. 341 
report that among smokers asked to vape for 6 weeks, those given a menthol/tobacco flavour smoked 342 
less than those given cherry/chocolate(33). Longitudinal surveys are required to see whether changing 343 
flavour over time, as well as flavour choice at initiation, might be beneficial to sustained smoking 344 
cessation. Preferences for fruit/sweet/food flavours may have implications for areas where flavours are 345 
banned(34).   346 
 347 
 348 
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4.1. Limitations 349 
This study is cross-sectional and so cannot identify causative associations. It relied on 350 
retrospective reports of vaping practices which may be subject to recall bias. Data on cessation were 351 
self-reported and not biochemically verified.  352 
Another major limitation is missing data. Questions on flavours, device types, e-liquid nicotine 353 
concentration and vaping status were answered by more than 60% of participants, but questions on 354 
smoking status were answered by 56.9% of participants and questions on relapse, the main outcome 355 
variable, were only answered by 42% of participants. Many participants did not complete all questions, 356 
meaning some analyses are underpowered and some potential confounders could not be included in 357 
regression models. Pairwise deletion was used to manage missing data instead of multiple imputation, 358 
which may have been a more robust approach(35).  359 
This survey recruited a convenience sample of e-cigarette users, likely representing those who 360 
were successful and wished to share their experiences. Whilst not representative of the wider 361 
population of vapers, it does suggest ways in which smokers who have successfully switched to vaping 362 
may have achieved this successful transition.   363 
Demographic characteristics of participants in this survey were compared with those of Smoking 364 
Toolkit Study participants who smoked cigarettes or any other tobacco product daily or occasionally at 365 
the time of the survey or during the preceding 12 months(Table 3)(36). This suggested our sample were 366 
more likely to be of higher social grade and the percentage of female participants is much lower, which 367 
may be related to the perceived masculinity of vaping(22). Mean reported CPD before cessation was 368 
33.8 in this study, much higher than the 2015 UK average of 11.3(36).   369 
Weaver et al. highlight the variations in terminology (e.g. e-cigarette, vaping) and device 370 
descriptions (e.g. mod, personal vaporizer) among consumers and researchers(37). This survey 371 
attempted to overcome these challenges by permitting participants to describe devices in their own 372 
words, but this was poorly completed, and the survey had to be adapted to a multiple-choice option.   373 
None of the survey participants reported using Pod devices as these were not commonly used in 374 
the UK when the survey was conducted and so we are unable to comment on the potential role of these 375 
devices. Further research is needed into the effectiveness of these devices for sustained smoking 376 
cessation as their popularity grows.  377 
 378 
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 379 
 380 
Table 3. Comparison of participant demographics with the Smoking Toolkit Study.  381 
 Smoking Toolkit Study This study (ECtra) 
Mean age 39.5 (SD 15.6) 49 (SD 11.61) 
Female (%) 54 23.63 
Social grade (% in each 
category) 
  
A 10.7 (A + B) 10.5 (n=17) 
B  8.6 (n=14) 
C1 22.9 38.3 (n=62) 
C2 22.7 9.3 (n=15) 
D 18.8 15.4 (n=25) 
E 24.8 17.9 (n=29) 
 382 
4.2. Future research 383 
There is a need for studies on relapse to smoking among e-cigarette users that follow people up 384 
over time, providing data on trajectories, to understand how users experience progressing from simpler 385 
to more modern devices. If followed up over a long period, trends in e-cigarette use could be assessed, 386 
including whether people switching to e-cigarettes now or in the future are more likely to use a more 387 
modern device and so need a lower nicotine strength. Studies may consider how those switching from 388 
tobacco could be supported to choose a suitable device and strength, perhaps through working with 389 
vape shops and online retailers.     390 
 Future research could explore the potential role of flavours in relapse. Qualitative studies have 391 
suggested that perceiving e-cigarettes as something very different from tobacco smoking, rather than 392 
a substitute, is important for some vapers in avoiding a return to smoking(15). The results of this study 393 
suggest a transition over time away from devices that look and feel like tobacco cigarettes, but further 394 
research is needed to investigate associations between e-liquid flavor and tobacco smoking relapse.  395 
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5. Conclusions 396 
The results of this study suggest the choice of e-cigarette products and liquids used may have an 397 
impact on relapse to tobacco smoking. Those initiating vaping with a less sophisticated device and/or 398 
lower nicotine strength e-liquid may be at higher risk of relapse to tobacco smoking. Self-report patterns 399 
of device use by vapers suggest changing patterns over time, with many users moving from less 400 
sophisticated, tobacco flavoured cig-a-like devices, to more sophisticated tank devices with 401 
fruit/sweet/food flavours. 402 
 403 
 404 
 405 
 406 
 407 
 408 
 409 
 410 
 411 
 412 
 413 
 414 
 415 
 416 
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